Related references
Note: Only part of the references are listed.A novel homozygous SCO2 mutation, p.G193S, causing fatal infantile cardioencephalomyopathy
B.C. Mobley et al.
CLINICAL NEUROPATHOLOGY (2011)
Periventricular heterotopia, mental retardation, and epilepsy associated with 5q14.3-q15 deletion
C. Cardoso et al.
NEUROLOGY (2009)
Lateral-flow immunoassay for the frataxin protein in Friedreich's ataxia patients and carriers
John H. Willis et al.
MOLECULAR GENETICS AND METABOLISM (2008)
Mitochondrial Disease in Autism Spectrum Disorder Patients: A Cohort Analysis
Jacqueline R. Weissman et al.
PLOS ONE (2008)
Developmental regression and mitochondrial dysfunction in a child with autism
Jon S. Poling et al.
JOURNAL OF CHILD NEUROLOGY (2006)
Retrospective, multicentric study of 180 children with cytochrome c oxidase deficiency
M Bohm et al.
PEDIATRIC RESEARCH (2006)
Genome-wide aberrations in pancreatic adenocarcinoma
NJ Nowak et al.
CANCER GENETICS AND CYTOGENETICS (2005)
Mitochondrial dysfunction in autism spectrum disorders:: a population-based study
G Oliveira et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2005)
Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease
F Scaglia et al.
PEDIATRICS (2004)
Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay:: HEADD syndrome
JJ Filiano et al.
JOURNAL OF CHILD NEUROLOGY (2002)
Very large G protein-coupled receptor-1, the largest known cell surface protein, is highly expressed in the developing central nervous system
DR McMillan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A genomewide linkage-disequilibrium scan localizes the Saguenay-Lac-Saint-Jean cytochrome oxidase deficiency to 2p16
N Lee et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)